Medtronic Inc. (MDT) is in the Health Care Industry

• Sort by
• View by Content Type

• Medtronic to Cut About 1,100 Jobs

  By Susan Kelly CHICAGO (Reuters) - Medtronic Inc MDT on Tuesday said it would eliminate about 1,100 jobs this year, or almost 3 percent of its work force, in businesses whose growth has slowed, including its flagship heart rhythm device unit. The company...

  News items 2008-05-06

  Tags: Mergers & Acquisitions, Financial accounting, HEALTHCARE, Medtronic Inc., medical device, earnings, Chicago, Thomson Reuters Corp., acquisition

• Medical Device Makers: Ranked by Number of Employees in the Greater San Fernando Valley

  Among the largest medical device makers in the greater San Fernando Valley are Medtronic Diabetes (No. 1) with 2,000 employees, St. Jude Medical (No. 2) with 1,600, and Advanced Bionics (No. 3) with 600. Overall, St. Jude Medical is the largest medical device company with offices in the greater San...

  White papers 2006-01-16

  Tags: HEALTHCARE, AllBusiness.com, St. Jude Medical Inc., Medtronic Inc., medical device

• Lessons in Innovation: The Heart Failure Case Study

  Heart failure is a condition in which the heart can no longer pump enough blood to meet the body's needs. This article illustrates both the challenges and opportunities the device industry faces. In discussing the challenges and opportunities, this article describes the efforts at Medtronic over the last 13 years...

  White papers 2004-10-19

  Tags: Medtronic Inc.

Additional Resources

• Visiogen Appoints Kevin Hykes as Chief Commercial Officer

  IRVINE, Calif. -- Visiogen, Inc. has named Kevin Hykes to the position of Chief Commercial Officer, effective immediately. In this role, Mr. Hykes will be responsible for developing the global commercial plan for the Synchrony[R] dual optic accommodating intraocular lens. Mr. Hykes brings significant medical device experience to...

  Articles 2008-05-14

• Medtronic Announces FDA Approval of New Vision 3D Wireless Implantable Cardiac Devices

  Portfolio Includes the Industry's First Defibrillators with Complete Automaticity MINNEAPOLIS & SAN FRANCISCO -- Leading into Heart Rhythm 2008, the pre-eminent worldwide gathering of cardiologists specializing in electrophysiology, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration FDA approval of the first wave of cardiac rhythm...

  Articles 2008-05-13

• Thrombus Aspiration before Stenting Benefits Patients Suffering Myocardial Infarction, Study Shows

  Medtronic's Export([R]) Aspiration Catheter to Be Featured in Late-Breaking Clinical Trials and Other Sessions at EuroPCR MINNEAPOLIS & BARCELONA, Spain -- Medtronic, Inc. (NYSE: MDT) announced today the presentation of new results from an independent study, which show that thrombus aspiration with Medtronic's Export Aspiration Catheter prior to...

  Articles 2008-05-13

• ENDEAVOR II Four-Year Results Demonstrate Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting Stent

  Update at EuroPCR Shows Sustained Superiority of Endeavor([R]) DES over Bare-Metal Control MINNEAPOLIS & BARCELONA, Spain -- Today at EuroPCR, Medtronic, Inc. (NYSE: MDT), released four-year data from the ENDEAVOR II clinical trial that reinforces the long-term safety and durable efficacy of the company's Endeavor Zotarolimus-Eluting Coronary Stent...

  Articles 2008-05-13

• Medtronic Announces Start of International Study Comparing Endeavor® Resolute Drug-Eluting Stent to Abbott's Xience® V

  First Implants in Pivotal RESOLUTE III Trial Occur in Europe; Now Available in More Than 100 Countries Outside the U.S., Second Next-Generation DES Has Expanded Treatment Options for Patients with Coronary Artery Disease MINNEAPOLIS -- Continuing its commitment to clinical excellence, Medtronic, Inc. (NYSE: MDT), today...

  Articles 2008-05-12

• Medtronic Anticipates 'Practice-Changing' Clinical Data for Interventional Cardiologists at EuroPCR

  ENDEAVOR II Four-Year Results, Updated ENDEAVOR Pooled Safety Analysis, One-Year Results from E-Five Registry and TAPAS Trial - All Feature on Meeting's Scientific Program MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT), today announced plans for the release of new clinical data on the Endeavor([R]) Zotarolimus-Eluting Coronary Stent System and the...

  Articles 2008-05-12

• InSet Technologies Appoints Jon Tremmel to its Board of Directors

  MT. OLIVE, N.J., May 9 /PRNewswire/ -- InSet Technologies, an emerging leader in the development of implantable drug infusion pumps for targeted delivery of medications, announced today the addition of Jon Tremmel to its Board of Directors. Before retiring from Medtronic Inc. after nearly 30 years of...

  Articles 2008-05-09

• Medtronic, Inc. Webcast Notice

  Medtronic Institutional Investor and Analyst Meeting; Monday, June 2, 2008; 9 a.m.-12:30 p.m. Eastern Daylight Time; 8 a.m.-11:30 a.m. Central Daylight Time MINNEAPOLIS -- Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 2, 2008 in New York City from 9 a.m. -...

  Articles 2008-05-09

• Medtronic to Participate in the Citigroup Global Health Care Conference

  MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced that it will participate in the Citigroup 2008 Healthcare conference on Thursday, May 22, 2008 in New York, NY. Gary Ellis, senior vice president and chief financial officer of Medtronic, will speak to the...

  Articles 2008-05-08

• Major Changes in Store for the US Drug-Eluting Stent Market

  Millennium Research Group's MarketrackTM results find launch of Medtronic's Endeavor has altered market dynamics WALTHAM, Mass., May 8 /PRNewswire/ -- Millennium Research Group's (MRG's) Interventional Cardiology MarketrackTM results indicate that Medtronic's drug eluting stent DES, Endeavor, captured significant US market share and was the primary driver of...

  Articles 2008-05-08

• Medtronic Initiates Voluntary Field Actions for Selected Heparin-Coated Products Used During Cardiopulmonary Bypass

  MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT) today announced that it is initiating a voluntary and precautionary recall of selected products featuring the Carmeda BioActive surface. The affected devices are disposable products used during cardiopulmonary bypass CPB for heart surgeries. Affected products include blood oxygenators, reservoirs, pumps, cannulae, and tubing packs....

  Articles 2008-05-07

• Sigma-Aldrich Shareholders Elect Directors and Ratify Auditor; Directors Declare Quarterly Dividend

  ST. LOUIS, May 6 /PRNewswire-FirstCall/ -- At the annual shareholders meeting of Sigma-Aldrich Corporation held today in St. Louis, the following directors were re-elected: David R. Harvey, W. Lee McCollum, Jai P. Nagarkatti, Avi M. Nash, Steven M. Paul, J. Pedro Reinhard, Timothy R. G. Sear, D....

  Articles 2008-05-06

• Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year Ended April 25, 2008

  Webcast Scheduled for 7 a.m. CDT, May 20, 2008 MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT), announced today it will report financial results for its fourth quarter and fiscal year, which ended April 25, 2008, on Tuesday, May 20, 2008. A news release with summary financial information will be...

  Articles 2008-05-06

• Medtronic Annual Meeting Date Scheduled for August 21, 2008

  MINNEAPOLIS -- The board of directors of Medtronic, Inc. (NYSE: MDT), today announced that the company's annual meeting of shareholders will be held at 10:30 a.m., Central Daylight Time, on Thursday, August 21, 2008 at Medtronic World Headquarters, located at 710 Medtronic Parkway, Minneapolis, Minnesota. Shareholders of record at the...

  Articles 2008-05-05

• Medtronic Announces 2008 "Global Heroes"

  Distance Runners from Around the World Who Benefit from Medical Technology To Run this Fall in Medtronic Twin Cities Marathon Events MINNEAPOLIS -- Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: MEDTRONIC ANNOUNCES 2008 "GLOBAL...

  Articles 2008-05-02

• CoreValve Names Daniel T. Lemaitre as Chief Executive Officer

  IRVINE, Calif. -- CoreValve (www.corevalve.com) announced today that it has appointed Daniel T. Lemaitre as Chief Executive Officer, effective immediately. He succeeds Jacques Seguin, M.D., Ph.D., co-founder of CoreValve, who will remain as Chairman of the Board. Mr. Lemaitre has led Medtronic's corporate strategic planning and corporate development...

  Articles 2008-04-30

• Virginia Judge Rules Medical Device Pioneer Committed Malpractice

  RICHMOND, Va., April 29 /PRNewswire/ -- The principal U.S. investigator for the MaverickTM artificial disc device has been found liable for malpractice in his use of the device by a state court judge in Richmond, Va. Garver v. Mathews, CL No. 07-206, Circuit Court, City of Richmond, Va. ...

  Articles 2008-04-29